GATA3 and carcinoma: That only 40% of GATA3 high-level amplificated carcinomas showed strong GATA3 immunostaining while 12% were entirely GATA3 negative demonstrates that GATA3 amplification is neither required nor sufficient to induce strong GATA3 expression in these tumors.